| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| United States | Region | 2025 | USD | 2,264.3 | 98.2% |
| Europe, Middle East, India, and Africa | Region | 2025 | USD | 24.5 | 1.1% |
| Americas, excluding U.S. | Region | 2025 | USD | 9.4 | 0.4% |
| Asia Pacific and Other | Region | 2025 | USD | 8.0 | 0.4% |
| United States | Region | 2024 | USD | 1,657.7 | 97.7% |
| Europe, Middle East, India, Africa | Region | 2024 | USD | 23.9 | 1.4% |
| Asia Pacific and Other | Region | 2024 | USD | 8.7 | 0.5% |
| Americas, excluding U.S. | Region | 2024 | USD | 6.6 | 0.4% |
| United States | Region | 2023 | USD | 1,047.6 | 96.8% |
| Europe, Middle East, India, Africa | Region | 2023 | USD | 22.8 | 2.1% |
| Asia Pacific and Other | Region | 2023 | USD | 7.2 | 0.7% |
| Americas, excluding U.S. | Region | 2023 | USD | 4.9 | 0.5% |
| United States | Region | 2022 | USD | 785.8 | 95.8% |
| Europe, Middle East, India, Africa | Region | 2022 | USD | 16.6 | 2.0% |
| Asia Pacific and Other | Region | 2022 | USD | 14.0 | 1.7% |
| Americas, excluding U.S. | Region | 2022 | USD | 3.7 | 0.5% |
| United States | Region | 2021 | USD | 590.9 | 94.5% |
| Europe, Middle East, India, and Africa | Region | 2021 | USD | 20.4 | 3.3% |
| Asia Pacific and Other | Region | 2021 | USD | 10.1 | 1.6% |
| Americas, excluding U.S. | Region | 2021 | USD | 4.0 | 0.7% |
| U | Region | 2020 | USD | 365.7 | 93.5% |
| Europe Middle East India And Africa | Region | 2020 | USD | 14.3 | 3.7% |
| Other Geographic Areas | Region | 2020 | USD | 7.5 | 1.9% |
| Americas Excluding Us | Region | 2020 | USD | 3.5 | 0.9% |
| Product | Product | 2025 | USD | 2,295.8 | 99.6% |
| Licensing and other | Product | 2025 | USD | 10.3 | 0.5% |
| Product | Product | 2024 | USD | 1,685.1 | 99.3% |
| Licensing and other | Product | 2024 | USD | 11.8 | 0.7% |
| Product | Product | 2023 | USD | 1,068.5 | 95.4% |
| Oncology products | Product | 2023 | USD | 19.3 | 1.7% |
| Genetic testing services | Product | 2023 | USD | 18.3 | 1.6% |
| Licensing and other | Product | 2023 | USD | 14.0 | 1.3% |
| Product | Product | 2022 | USD | 797.3 | 97.2% |
| Licensing and other | Product | 2022 | USD | 22.9 | 2.8% |
| Product | Product | 2021 | USD | 567.1 | 90.7% |
| Licensing and other | Product | 2021 | USD | 58.3 | 9.3% |
| Product | Product | 2020 | USD | 367.2 | 93.9% |
| Licensing And Other | Product | 2020 | USD | 23.8 | 6.1% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
